## Abstract Bone marrow‐derived mesenchymal stem cells (MSCs) are being explored for clinical applications, and genetic engineering represents a useful strategy for boosting the therapeutic potency of MSCs. Vascular endothelial growth factor (VEGF)‐based gene therapy protocols have been used to tre
Age-related gene expression profiles of rhesus monkey bone marrow-derived mesenchymal stem cells
✍ Scribed by Joseph G. Hacia; C. Chang I. Lee; Daniel F. Jimenez; Mazen W. Karaman; Vincent V. Ho; Kimberley D. Siegmund; Alice F. Tarantal
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 270 KB
- Volume
- 103
- Category
- Article
- ISSN
- 0730-2312
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
The objective of this study was to elucidate age‐related differences in gene expression profiles of rhesus monkey bone marrow‐derived mesenchymal stem cells (rhMSC) obtained from fetal, infant, and adult donors relevant to their growth and other properties. Although a high degree of similarity was observed in the rhMSC gene expression profiles when comparing the three age groups, significant differences were found that strongly parallel gene expression profiles of human MSC. In general, there was a trend towards increased abundance of transcripts associated with differentiation and growth arrest with increasing donor age. Conversely, transcripts involved in RNA processing and the negative regulation of gene expression showed a downward trend with increasing donor age. Overall, the observed gene expression profiles were found to be similar to observations that MSC from older individuals show diminished proliferative capacity. These data highlight the importance of use of non‐human primates to study the properties of stem and progenitor cells, and for future therapies. J. Cell. Biochem. 103: 1198–1210, 2008. © 2007 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## Abstract Human adult bone marrow–derived neural stemlike cells (MDNSCs) may serve as ideal seed cells for cell replacement therapy for human neurological disorders and injuries. However, the long‐term safety of this cell population after transplantation must be thoroughly explored before clinica
## Abstract ## Objective To compare the chondrogenic potential of human bone marrow–derived mesenchymal stem cells (BMSC) and adipose tissue–derived stromal cells (ATSC), because the availability of an unlimited cell source replacing human chondrocytes could be strongly beneficial for cell therapy
## Abstract Adult bone marrow cells (BMCs) include two populations:;mesenchymal stem cells (MSCs), which can differentiate into bone, cartilage, and fat; and hematopoietic stem cells (HSCs), which produce all mature blood lineage. To study the effect of aging, gender, and age‐related disorders on l